Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH.

Menopause. 2017 Oct;24(10):1101-1112. doi: 10.1097/GME.0000000000000983. No abstract available.

PMID:
28872490
2.

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH.

Climacteric. 2017 Oct;20(5):402-413. doi: 10.1080/13697137.2017.1362156. Epub 2017 Aug 14. Erratum in: Climacteric. 2017 Oct;20(5):503.

PMID:
28805475
3.

The evidence base for HRT: what can we believe?

Langer RD.

Climacteric. 2017 Apr;20(2):91-96. doi: 10.1080/13697137.2017.1280251. Epub 2017 Mar 10. Review.

PMID:
28281363
4.

2016 IMS Recommendations on women's midlife health and menopause hormone therapy.

Baber RJ, Panay N, Fenton A; IMS Writing Group.

Climacteric. 2016 Apr;19(2):109-50. doi: 10.3109/13697137.2015.1129166. Epub 2016 Feb 12.

PMID:
26872610
5.

Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus.

Daka B, Langer RD, Larsson CA, Rosén T, Jansson PA, Råstam L, Lindblad U.

BMC Endocr Disord. 2015 Jul 25;15:35. doi: 10.1186/s12902-015-0034-1.

6.

Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.

Langer RD, Manson JE, Allison MA.

Climacteric. 2012 Jun;15(3):206-12. doi: 10.3109/13697137.2012.666916. Review.

PMID:
22612605
7.

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.

Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL; WHI Investigators.

JAMA. 2010 Oct 20;304(15):1684-92. doi: 10.1001/jama.2010.1500.

8.

Vasomotor symptoms and coronary artery calcium in postmenopausal women.

Allison MA, Manson JE, Aragaki A, Langer RD, Rossouw J, Curb D, Martin LW, Phillips L, Stefanick ML, Cochrane BB, Sarto G, Barnhart J, O'Sullivan MJ, Johnson KC, Gass M, Trevisan M, Woods NF.

Menopause. 2010 Nov-Dec;17(6):1136-45. doi: 10.1097/gme.0b013e3181e664dc.

9.

On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.

Langer RD.

Climacteric. 2010 Aug;13(4):303-6. doi: 10.3109/13697137.2010.496316.

PMID:
20540591
10.

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.

Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O'Sullivan MJ, Ockene JK, Chen C, Hubbell FA; Women's Health Initiative Investigators.

Lancet. 2009 Oct 10;374(9697):1243-51. doi: 10.1016/S0140-6736(09)61526-9. Epub 2009 Sep 18.

11.

Efficacy, safety, and tolerability of low-dose hormone therapy in managing menopausal symptoms.

Langer RD.

J Am Board Fam Med. 2009 Sep-Oct;22(5):563-73. doi: 10.3122/jabfm.2009.05.080134. Review.

12.

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.

Am J Epidemiol. 2009 Jul 1;170(1):12-23. doi: 10.1093/aje/kwp115. Epub 2009 May 25.

13.

Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial.

McTiernan A, Wactawski-Wende J, Wu L, Rodabough RJ, Watts NB, Tylavsky F, Freeman R, Hendrix S, Jackson R; Women's Health Initiative Investigators.

Am J Clin Nutr. 2009 Jun;89(6):1864-76. doi: 10.3945/ajcn.2008.26956. Epub 2009 Apr 29.

14.

Breast cancer after use of estrogen plus progestin in postmenopausal women.

Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G; WHI Investigators.

N Engl J Med. 2009 Feb 5;360(6):573-87. doi: 10.1056/NEJMoa0807684.

15.

Abdominal aortic aneurysm events in the women's health initiative: cohort study.

Lederle FA, Larson JC, Margolis KL, Allison MA, Freiberg MS, Cochrane BB, Graettinger WF, Curb JD; Women's Health Initiative Cohort Study.

BMJ. 2008 Oct 14;337:a1724. doi: 10.1136/bmj.a1724.

16.

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.

Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT; Women's Health Initiative Investigators.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2609-18. doi: 10.1158/1055-9965.EPI-08-0385. Epub 2008 Sep 30.

17.

Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative.

Brunner RL, Cochrane B, Jackson RD, Larson J, Lewis C, Limacher M, Rosal M, Shumaker S, Wallace R; Women's Health Initiative Investigators.

J Am Diet Assoc. 2008 Sep;108(9):1472-9. doi: 10.1016/j.jada.2008.06.432.

18.

Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux.

Zheng Z, Margolis KL, Liu S, Tinker LF, Ye W; Women's Health Initiative Investigators.

Gastroenterology. 2008 Jul;135(1):72-81. doi: 10.1053/j.gastro.2008.03.039. Epub 2008 Mar 25.

19.

Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events.

Bray PF, Larson JC, Lacroix AZ, Manson J, Limacher MC, Rossouw JE, Lasser NL, Lawson WE, Stefanick ML, Langer RD, Margolis KL; Women's Health Initiative Investigators.

Am J Cardiol. 2008 Jun 1;101(11):1599-1605. doi: 10.1016/j.amjcard.2008.01.043. Epub 2008 Apr 2.

20.

Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study.

Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, Phillips L, Cochrane BB, Eaton CB, Greenland P, Hendrix S, Hsia J, Hunt JR, Jackson RD, Johnson KC, Kuller LH, Robinson J; Women's Health Initiative and Women's Health Initiative Coronary Artery Calcium Study Investigators.

Menopause. 2008 Jul-Aug;15(4 Pt 1):639-47. doi: 10.1097/gme.0b013e31816d5b1c.

Supplemental Content

Loading ...
Support Center